Biography and Research Information
OverviewAI-generated summary
Sarenthia M. Epps' research focuses on the intersection of critical care, infectious diseases, and drug-induced pathologies, particularly in the context of severe illnesses like COVID-19. Her work has investigated adverse effects associated with medications used in intensive care settings, such as tocilizumab, and their association with increased risks of fungal infections and acute renal failure. Epps has also examined specific clinical presentations, including a case study of a male patient experiencing lightheadedness and dyspnea, and explored arterial thrombus formation in COVID-19 infections. Her publications include observational cohort studies and case reports, contributing to the understanding of complex patient outcomes in critical care environments. Epps has collaborated with researchers at the University of Arkansas for Medical Sciences, including Nikhil Meena, William T. Atchley, Rajani Jagana, and Barrett J. Burger, on multiple shared publications.
Metrics
- h-index: 4
- Publications: 8
- Citations: 42
Selected Publications
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)
-
A 34-Year-Old Man With Lightheadedness and Dyspnea (2022)
-
Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021)
Collaboration Network
Top Collaborators
Nikhil Meena
University of Arkansas for Medical Sciences
4 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Barrett J. Burger
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Víctor M. Cárdenas
University of Arkansas for Medical Sciences (US)
3 shared publications
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Rajani Jagana
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
William T. Atchley
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Anand N. Venkata
University of Arkansas for Medical Sciences
2 shared publications
In database
- TACROLIMUS-INDUCED LUNG INJURY
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Raga Deepak Reddy Palagiri
1 shared publication
- TWO CASES OF ARTERIAL THROMBUS IN COVID-19 INFECTION
Harmeen Goraya
1 shared publication
In database
- TWO CASES OF ARTERIAL THROMBUS IN COVID-19 INFECTION
Abhishek Kumar
University of Arkansas for Medical Sciences (US)
1 shared publication
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Susanne K. Jeffus
University of Arkansas for Medical Sciences
1 shared publication
In database
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Jose Diego Caceres
University of Arkansas for Medical Sciences
1 shared publication
In database
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Jonathan Killam
Northwell Health (US)
1 shared publication
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Similar Researchers
Based on overlapping research topics
Barrett J. Burger
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Z. Chauhan
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Emergency and Acute Care Studies
Spencer Parnell
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Pharmacological Effects and Toxicity Studies
Emergency and Acute Care Studies
Joe Brown
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Disease Mechanisms Research
Medical Case Studies
Caroline G. Geels
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Disease Mechanisms Research
Jorge Brito
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies